Original Article
Comparison of the Total Side Effects of Injectable Disease-Modifying Drugs for the First-line Treatment of Relapsing-Remitting Multiple Sclerosis
Masoud Ghiasian 1 
, Seyedeh Anis Rashidizad 2, Mojdeh Mohammadi 3, Younes Mohammadi 4, Sara Ataei 2 *